CHICAGO, December 16, 2019 — The ¸£Àû¼§ÊÓƵ (ADA) today announced a new interim policy on vaping, calling for a total ban on vaping products that aren’t approved by the Food and Drug Administration (FDA) for tobacco cessation purposes.
The policy states that the ADA:
- Urgently advocate for regulatory, legislative, and/or legal action at the federal and/or state levels to ban the sale and distribution of all e-cigarette and vaping products, with the exception of those approved by the FDA for tobacco cessation purposes and made available by prescription only; and
- Advocate for research funding to study the safety and effectiveness of e-cigarettes and vaping products for tobacco cessation purposes and their effects on the oral cavity.
The policy mirrors recent action taken by the American Medical Association and is a call to action to ensure the health and safety of consumers.
“While the long-term oral health effects of vaping are under scientific review, as health professionals we must be prudent in protecting consumers from potentially harmful products,” said ¸£Àû¼§ÊÓƵPresident Chad Gehani, D.D.S. “We will continue to advocate for additional research, but we must protect the health of our patients first and foremost. A ban such as this would ensure patient safety while allowing us to explore the impact of vaping products on oral health.”
The ¸£Àû¼§ÊÓƵhas advocated for the development of a body of scientific research examining the oral effects of both tobacco and non-tobacco nicotine delivery products as part of the ¸£Àû¼§ÊÓƵpolicy on tobacco use. In addition to this interim policy, in September, the ¸£Àû¼§ÊÓƵHouse of Delegates passed a resolution stipulating that the word “vaping” and any other alternative nicotine delivery systems be added to the existing ¸£Àû¼§ÊÓƵpolicy focused on tobacco use prevention, research and regulation.
For more information about the ADA’s advocacy efforts around vaping and tobacco products, visit ADA.org/vaping.